Aurelia de Pauw
Corporate Officer/Principal at TETRA BIO-PHARMA INC.
Aurelia de Pauw active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TETRA BIO-PHARMA INC. | Corporate Officer/Principal | 2018-09-30 | - |
TALLC Corp., Inc.
 TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | Director/Board Member | - | - |
Career history of Aurelia de Pauw
Training of Aurelia de Pauw
| Faculté Universitaire des Sciences Agronomiques de Gembloux | Graduate Degree |
| Université de Namur ASBL | Doctorate Degree |
Statistics
International
| Canada | 3 |
| Belgium | 3 |
Operational
| Corporate Officer/Principal | 1 |
| Graduate Degree | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| TETRA BIO-PHARMA INC. | Health Technology |
| Private companies | 1 |
|---|---|
TALLC Corp., Inc.
TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | Health Technology |
- Stock Market
- Insiders
- Aurelia de Pauw
- Experience
